MedPath

COMPARATIVE TREATMENT OF BIOPURIFICATION AND AUSHADH CHIKITSA IN VICHARCHIKA(KUSTHA)

Phase 2/3
Not yet recruiting
Conditions
Dermatitis, unspecified,
Registration Number
CTRI/2020/03/024115
Lead Sponsor
Chaudhary Brahm Prakash Ayurved Charak Sansthan
Brief Summary

this study is a open label parallel group trial comparing the shodhana and shamana chikitsa in vicharchika. in one group vaman with madanphala Churan will be given followed by Virechan with Abhyadi Modak . in another group arogyavardhini vati  as shamana chikitsa will be given.the trial will be conducted in ch. brahm prakash ayurved charak sansthan india.with primary outcome of improvement in EASI SCORE and

secondary outcome in symptoms of vicharchika..

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • •Patients of either sex between 20 to 60 years of age.
  • •Patients diagnosed as a case of Vicharchika on the basis of Lakshanas : 1.Kandu (Iching) 2.Pidaka(Eruption) 3 Shyavavarna (Depigmentation) 4.
  • Rukshata (Dryness) according to the clinical features as described in Charak samhita will be selected irrespective of gender/ occupation and socio-economic status.
  • •Disease duration > 6 month •Willing to sign the consent for study participation.
Exclusion Criteria
  • •Patients on allopathic treatment.
  • •Patients who are unfit for shodhana karma as per text.
  • •Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
EASI SCOREAfter Vaman Karma, After Virechana Karma,On 60th day
Secondary Outcome Measures
NameTimeMethod
symptoms of vicharchikaAfter Vaman Karma, After Virechana Karma,on 60th day

Trial Locations

Locations (1)

Chaudhary Brahm prakash Ayurved Charak Sansthan

🇮🇳

West, DELHI, India

Chaudhary Brahm prakash Ayurved Charak Sansthan
🇮🇳West, DELHI, India
DR MAHESH KHUNDIA
Principal investigator
9467675037
maheshkhundia786@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.